Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.

Hewamana S, Lin TT, Jenkins C, Burnett AK, Jordan CT, Fegan C, Brennan P, Rowntree C, Pepper C.

Clin Cancer Res. 2008 Dec 15;14(24):8102-11. doi: 10.1158/1078-0432.CCR-08-1673.

2.
3.

NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.

Lopez-Guerra M, Colomer D.

Expert Opin Ther Targets. 2010 Mar;14(3):275-88. doi: 10.1517/14728221003598930. Review.

PMID:
20148715
4.

Signalling to drug resistance in CLL.

Hertlein E, Byrd JC.

Best Pract Res Clin Haematol. 2010 Mar;23(1):121-31. doi: 10.1016/j.beha.2010.01.007. Review.

PMID:
20620976
5.

Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).

Van den Neste E, Cardoen S, Offner F, Bontemps F.

Int J Oncol. 2005 Oct;27(4):1113-24. Review.

PMID:
16142330
6.

Mechanism of action of purine analogues in chronic lymphocytic leukaemia.

Pettitt AR.

Br J Haematol. 2003 Jun;121(5):692-702. Review. No abstract available.

PMID:
12780783
7.
8.

[Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].

Yao L, Xu W, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):821-4. Review. Chinese.

PMID:
20561458
9.

The treatment of relapsed refractory chronic lymphocytic leukemia.

Brown JR.

Hematology Am Soc Hematol Educ Program. 2011;2011:110-8. doi: 10.1182/asheducation-2011.1.110. Review.

PMID:
22160021
10.

Pentostatin in chronic lymphocytic leukemia.

Sauter C, Lamanna N, Weiss MA.

Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1217-22. doi: 10.1517/17425255.4.9.1217. Review.

PMID:
18721115
11.

Role of angiogenesis in chronic lymphocytic leukemia.

Letilovic T, Vrhovac R, Verstovsek S, Jaksic B, Ferrajoli A.

Cancer. 2006 Sep 1;107(5):925-34. Review.

12.
13.

CD154 gene therapy for human B-cell malignancies.

Messmer D, Kipps TJ.

Ann N Y Acad Sci. 2005 Dec;1062:51-60. Review.

PMID:
16461788
14.

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia.

Pepper C, Hewamana S, Brennan P, Fegan C.

Future Oncol. 2009 Sep;5(7):1027-37. doi: 10.2217/fon.09.72. Review.

PMID:
19792971
15.

Role of fludarabine in hematological malignancies.

Montillo M, Ricci F, Tedeschi A.

Expert Rev Anticancer Ther. 2006 Sep;6(9):1141-61. Review.

PMID:
17020450
16.

Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: case report and review of literature.

Leung WH, Tsang SF, Chim CS.

Am J Hematol. 2005 Jul;79(3):246-7. Review. No abstract available.

17.

The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.

Sampath D, Plunkett W.

Curr Oncol Rep. 2007 Sep;9(5):361-7. Review.

PMID:
17706164
18.

[Clinical pharmacology of fludarabine].

Robak T, Drzewoski J.

Pol Tyg Lek. 1991 Dec 2-9;46(48-49):942-4. Review. Polish. No abstract available.

PMID:
1845714
19.

[Chronic lymphocytic leukemia and the related disorders].

Karasawa M.

Rinsho Ketsueki. 2008 Oct;49(10):1394-400. Review. Japanese. No abstract available.

PMID:
18833924

Supplemental Content

Support Center